ABC | Volume 114, Nº1, Janeiro 2020

Artigo Original Leite et al. Espessura carotídea em pacientes infectados pelo HIV Arq Bras Cardiol. 2020; 114(1):90-97 1. World Health Organization (WHO). Global Health Observatory Data: Antiretroviral therapy (ART) coverage among all age groups. Geneva; 2015. 2. Ross AC, Rizk N, O’Riordan MA, Dogra V, El-Bejjani D, Storer N, et al. Relationshipbetween inflammatorymarkers,endothelialactivationmarkers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009;49(7):1119-27. 3. Kaplan RC, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, et al. Potential cardiovascular disease risk markers among HIV infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr. 2012;60(4):359-68. 4. Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, Kalapus SC, et al. Carotid intima-media thickness progression in HIV infected adults occurs preferentially at the carotid bifurcation and is predicted by inflammation. J AmHeart Assoc. 2012;1(2):pii:jah3-e000422. 5. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S-60S. 6. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein andHIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009;51(3):268-73. 7. Afiune Neto A, Souza AD, Lottenberg AMP, Chacra AP, Faludi AA, Loures- Vale AA, et al. IV Diretriz Brasileira sobre dislipidemias e Prevenção da Aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq. Bras. Cardiol. 2007;88(suppl. 1):1-19. 8. Godoi ETAM, Brandt CT, Godoi JTAM, Lacerda HR, Albuquerque VMG, Zirpoli JC, et al. Antirretroviral therapy effect in the intima-medio complex and ankle-brachial index in patients infected by HIV. J Vasc Bras. 2012;11(2):123-31. 9. Godoi ETAM, Brandt CT, Godoi JTAM, MeloHRL, Godoi JTAM. Assessment of intima-media complex in carotid, femoral and right subclavian arteries for early investigation of atherosclerosis in HIV-infected patients. Radiol Bras. 2013;46(6):2333-40. 10. Freire CMV, Alcantara ML, Santos SN, Amaral SI, Veloso O, Porto CLL, et al. Recomendação para a quantificação pelo ultrassom da doença aterosclerótica das artérias carótidas e vertebrais: grupo de trabalho do departamento de imagem cardiovascular da Sociedade Brasileira de Cardiologia – DIC – SBC. Arq Bras Cardiol. 2015;28(n. especial):e1-e64. 11. McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, Koethe JR, et al. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses. 2013;29(7):993-9. 12. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009;83(8):3719-33. 13. Haissman JM, Vestegaard LS, Sembuche S, Erikstrup C, Mmbando B, Mtullu S, et al. Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment. J Acquir Immune Defic Syndr. 2009;52(4):493-7. 14. Nguemaïm NF, Mbuagbaw J, Nkoat T, Alemnji G, Této G, Fanhi TC, et al. Serum lipid profile in highly active antiretroviral therapy-naiveHIV-infected patients in Cameroon: a case-control study. HIV Med. 2010;11(6):353-9. 15. Kuti MA, AdesinaOa, AwoludeOa, Ogunbosi BO, Fayemiwo SA, Akinyemi JO, et al. Dyslipidemia in ART-naive HIV-infected persons in Nigeria- implications for care. J Int Assoc Provid AIDS Care. 2015;14(4):355-9. 16. Lorenz MW, Stephan C, Harmjanz A, Staszewski S, Buehler A, Bickel M, et al. Both long-termHIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis. 2008;196(2):720-6. 17. Falcão Mda C, Zírpoli JC, Albuquerque VM, Markman Filho B, Araújo NA, Falcão CA, et al. Association of biomarkers with atherosclerosis and risk for coronary artery disease in patients with HIV. Arq Bras Cardiol. 2012;99(5):971-8. 18. Ssinabulya I, Kayima J, Longenecker C, Luwedde M, Semitala F, Kambbugu A, et al. Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda. PLoS One. 2014;9(2):e89537. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 97